Non-invasive treatment in the management of Peyronie's disease

Therapeutic Advances in Urology
Karen Randhawa, C J Shukla

Abstract

Peyronies disease (PD) is estimated to affect approximately 3-9% of men worldwide and maybe associated with pain, erectile dysfunction and penile deformity including shortening. The condition has significant debilitating effects on quality of life, self-esteem and psychological wellbeing in addition to sexual function. Surgical results add further to this by patients having dissatisfaction with various aspects of outcomes. Non-surgical management may allow patients to avoid the morbidities associated with surgery and still achieve improved functional and aesthetic outcomes. Several non-surgical options are currently being employed in the treatment of PD that may reduce or stabilize both objective measures (e.g. penile length and deformity) and subjective measures (including sexual function, pain and partner satisfaction). Nonsurgical management can allow patients to avoid the morbidities associated with surgery and still achieve improved functional and aesthetic outcomes. In this article we explore the current non-surgical management options for PD including oral, mechanical therapies, intralesional and topical treatments. We also briefly discuss future treatment options in the form of stem cell therapy.

References

Dec 1, 1975·The Journal of Urology·C C Winter, R Khanna
Jan 1, 1967·The Journal of Urology·P N Desanctis, C A Furey
Oct 1, 1980·British Journal of Urology·G Williams, N A Green
May 28, 1996·Proceedings of the National Academy of Sciences of the United States of America·M RothL H Block
Sep 26, 2000·International Journal of Impotence Research·M S AndersonJ P Mulhall
Mar 14, 2002·BJU International·U SchwarzerU Engelmann
Jul 20, 2002·The Journal of Urology·Laurence A LevineJason M Greenfield
Nov 28, 2002·International Journal of Impotence Research·J P MulhallT V Shankey
Nov 28, 2002·International Journal of Impotence Research·J P Pryor, D J Ralph
Apr 11, 2003·The Journal of Urology·Laurence A LevineAda Cole
Aug 26, 2003·Lipids·Subbiah YoganathanFrank Orthoefer
May 1, 1954·The Journal of Urology·G H TEASLEY
Oct 11, 2003·International Journal of Impotence Research·L A Levine
Feb 20, 2004·International Journal of Impotence Research·R T StrebelD Hauri
Jan 21, 2006·The Journal of Sexual Medicine·Muammer KendirciWayne J G Hellstrom
Jul 13, 2006·International Urology and Nephrology·T FaziliG R Mufti
Jul 15, 2006·The Journal of Sexual Medicine·Oluyemi Akin-OlugbadeJohn Mulhall
Nov 10, 2006·European Urology·Shane RussellKevin T McVary
Dec 6, 2006·Journal of Endourology·Shalom J SrirangamPatrick H O'Reilly
Jun 19, 2007·Urology·Nelson E BennettJohn P Mulhall
Sep 5, 2007·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Alvaro PaezUNKNOWN Grupo Urologico del Suroeste Madrileno (GUSOM)
Apr 1, 2008·The Journal of Sexual Medicine·Laurence A LevineFrederick L Taylor
Jun 17, 2008·The Journal of Sexual Medicine·Christian J NelsonJohn P Mulhall
Jul 22, 2008·The Journal of Sexual Medicine·James F SmithTom Lue
Sep 13, 2008·Cell Stem Cell·Mihaela CrisanBruno Péault
Mar 17, 2009·The Journal of Sexual Medicine·Nestor F Gonzalez-Cadavid
May 27, 2009·Current Reviews in Musculoskeletal Medicine·Steven SampsonBert Mandelbaum
Nov 9, 2010·The Journal of Sexual Medicine·Eric ChungGerald Brock
Sep 16, 2011·International Journal of Impotence Research·S M Larsen, L A Levine
Oct 26, 2011·The Journal of Sexual Medicine·Michael R AbernLaurence A Levine

❮ Previous
Next ❯

Citations

Jun 8, 2021·Frontiers in Pharmacology·Fuxun ZhangJiuhong Yuan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Urologic Clinics of North America
S M Larsen, Laurence A Levine
Indian Journal of Urology : IJU : Journal of the Urological Society of India
Aylin N Bilgutay, Alexander W Pastuszak
The World Journal of Men's Health
Gregory A Joice, Arthur L Burnett
© 2022 Meta ULC. All rights reserved